Pyrrole derivatives as pharmaceutical agents

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S226800, C514S230500, C514S255050, C514S300000, C514S314000, C514S368000, C514S375000, C514S405000, C514S456000, C514S434000, C544S091000, C544S048000, C544S405000, C546S275700, C546S121000, C546S167000, C546S173000, C546S176000, C546S122000, C549S360000, C549S218000, C549S315000

Reexamination Certificate

active

07087626

ABSTRACT:
Novel pyrrazole derivative compounds and their use as pharmaceutical agents, in particular their use as TGF-beta signal transduction inhibitors. The disclosed invention relates to compounds of the structure (I) wherein (I) is a four, five, or six membered saturated ring and X is C, O or S

REFERENCES:
patent: 5358947 (1994-10-01), Venkatesan
patent: 5670503 (1997-09-01), Kawai et al.
patent: 0 666 079 (1995-08-01), None
patent: 0 923 929 (1999-06-01), None
patent: 0 531 901 (1993-03-01), None
patent: WO 97 35551 (1997-10-01), None
patent: WO 98 52940 (1998-11-01), None
patent: WO 99 58128 (1999-11-01), None
patent: WO 00 61576 (2000-10-01), None
patent: WO 01 16138 (2001-03-01), None
patent: WO 01 72737 (2001-10-01), None
patent: WO 00 44743 (2001-11-01), None
patent: WO 02 16359 (2002-02-01), None
patent: WO 02 066462 (2002-08-01), None
patent: WO 02/034716 (2004-05-01), None
patent: WO 04/106604 (2004-06-01), None
XP-002210048;Effect of FR167653, a Cytokine Suppressive Agent, on Endotoxin-Induced Disseminated Intravascular Coagulation; Nobuchika Yamamotot, et al.; European Journal of Pharmacology 314; 1996; pp. 137-142.
XP-001096045;Effect of FR143430, a Novel Cytokine Suppressive Agent, on Adenocarcinoma Colon-26—Induced Cachexia in Mice; Nobuchika Yamamoto, et al; Anticancer Research 18; 1998; pp. 139-1444.
XP-001097427;Further Investigations on the Antiinflammatory Actvity of Some2-Phenylpyrozolo[1,5-a] Pyrimidine Compounds; R. Pirisino, et al; II Farmaco—Ed. Sci.; vol. 36, Fasc. 8; pp. 682-691.
XP-001097437;Pharmacological Activity of Some Pyrazolo[1,5-a] Pyrimidines; R. Pirisino; II Farmaco—Ec. Sc.; vol. 34—Fasc. 9; pp. 802-807.
Discovery of FR166124, A Novel Water-Soluble Pyrazolo-[1,5-a] Pyridine Adenosine A1Receptor Antagonist; Satour Kuroda, et al.; Bioorganic & Medicinal Chemistry Letters 9 (1999); pp. 1979-1984.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pyrrole derivatives as pharmaceutical agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrrole derivatives as pharmaceutical agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrole derivatives as pharmaceutical agents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3627499

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.